(Q33982898)

30 July 2017

1 reference

title

Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues (English)

1 reference

30 July 2017

1 reference

1 reference

Poles MA

1

1 reference

PubMed ID

10913414

30 July 2017

Dieterich DT

series ordinal

2

1 reference

PubMed ID

10913414

30 July 2017

language of work or name

English

0 references

publication date

25 July 2000

1 reference

Clinical Infectious Diseases

30 July 2017

1 reference

30 July 2017

31

1 reference

30 July 2017

1

1 reference

30 July 2017

154-161

1 reference

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

30 July 2017

1 reference

Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections

21 January 2018

1 reference

Hepatitis C virus infection in the mothers and infants cohort study

21 January 2018

1 reference

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

21 January 2018

1 reference

Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients

21 January 2018

1 reference

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants

21 January 2018

1 reference

Hepatitis C virus (HCV) RNA and human immunodeficiency virus (HIV) p24 antigen in the cryoglobulin of hemophiliacs with HIV and/or HCV infection

21 January 2018

1 reference

The natural history of chronic hepatitis C in haemophiliacs

21 January 2018

1 reference

The progression of HCV-associated liver disease in a cohort of haemophilic patients

21 January 2018

1 reference

Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C.

21 January 2018

1 reference

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival

21 January 2018

1 reference

Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro

21 January 2018

1 reference

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

21 January 2018

1 reference

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

21 January 2018

1 reference

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects

21 January 2018

1 reference

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

21 January 2018

1 reference

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

21 January 2018

1 reference

Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients

21 January 2018

1 reference

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

Effect of ribavirin on zidovudine efficacy and toxicity in vitro: a concentration-dependent interaction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313892

1 reference

30 July 2017

1 reference

PubMed ID

10913414